Human African trypanosomiasis (HAT), also known as sleeping sickness, has been a major
scourge afflicting populations in Africa in areas where its specific vector, the tsetse fly …

After the resurgence of sleeping sickness in Luba, Equatorial Guinea, a major campaign to
control the disease was established in 1985. The campaign comprised no vector control, but …

Publisher Summary In spite of the progress achieved, there are a number of future
challenges to pursue the way ahead. They can be divided into three categories …

Human African trypanosomiasis (HAT) or sleeping sickness is a vector-borne parasitic
disease characterized by the involvement of the central nervous system (CNS). Sleeping …

Background The World Health Organization (WHO) has targeted the elimination of Human
African trypanosomiasis (HAT)'as a public health problem'by 2020. The selected indicators …

Human African trypanosomiasis or sleeping sickness is an endemic disease in many sub-
Saharan countries. The causative agent is the unicellular haemoflagellate parasite …

Human African trypanosomiasis was considered a major public health problem in Luba,
Equatorial Guinea in 1985. Because of the lack of qualified personnel, the emergency …

Problems associated with the current therapies of sleeping sickness include toxicity,
resistance and a lack of a guaranteed supply. However, no new formulations are close to …

Background Over the last few years, momentum has gathered around the feasibility and
opportunity of eliminating gambiense human African trypanosomiasis (g-HAT). Under the …

Human African trypanosomiasis (HAT), despite considerable progress in the control, is still
occurring in many countries in both west and central African regions. The HAT situation in …